← SynDRA
NELOTANSERIN
SynDRA canonical compound SYN0020707 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | HTR2A |
| Mechanism of action | serotonin receptor inverse agonist |
All known targets
Mechanisms of action (all sources)
- HTR2A INVERSE AGONIST
- Serotonin 2a (5-HT2a) receptor inverse agonist
- serotonin receptor inverse agonist
- HTR2A MODULATOR
Cross-references
Synonyms
- Nelotanserine
- Nelotanserina
- APD-125
- APD125
- UNII-4ZA73QEW2P
- 4ZA73QEW2P
- CHEMBL598172
- APD 125
- 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea
- 1-[3-(4-BROMO-1-METHYL-1H-PYRAZOL-5-YL)-4-METHOXYPHENYL]-3-(2,4-DIFLUOROPHENYL)UREA
- N-[3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N'-(2,4-difluorophenyl)-Urea
- Nelotanserin [USAN:INN]
- Nelotanserin (USAN/INN)
- SCHEMBL2345325
- DTXSID40232868
- COSPVUFTLGQDQL-UHFFFAOYSA-N
- BCP24992
- ZINC38239930
- BDBM50324541
- AKOS027255058
- DB12555
- nelotanserinum
- RefChem:832142
- DTXCID70155359
- MFCD16619341
- C18H15BrF2N4O2
- APD125(Nelotanserin)?
- NELOTANSERIN [INN]
- NELOTANSERIN [USAN]
- orb1299895
- SCHEMBL29456962
- SCHEMBL29573017
- CHEBI:177438
- EX-A3147
- CS-5984
- SB19023
- AS-30117
- FB101032
Look up NELOTANSERIN in the interactive SynDRA portal →